04Mar
HHS Gives New Guidance on Drug Manufacturer Coupons and Out-of-Pocket Maximums
In April 2019, the Department of Health and Human Services (HHS) released guidance indicating that a health plan must include the value of financial assistance received from a drug manufacturer (often referred to as a “coupon” or “copay card”) when...
By:
Foley & Lardner LLP
Related
New York State Senator Kevin S. Parker recently introduced his bill, the New York Collegiate Athleti...
Read More >
Several weeks into the coronavirus pandemic, New York businesses remain subject to the provisions of...
Read More >
This week’s Update features a number of updates on previous stories, including our recent story on ...
Read More >
Perception is king – rejection for hearing impairment perceived disability discrimination - In The...
Read More >
During FY 2018, the Japan Fair Trade Commission ("JFTC") received 321 notifications, which is the la...
Read More >
The NILG/OFCCP Compensation Roundtable provided an interesting exchange between OFCCP Representative...
Read More >